These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 12124322)

  • 1. Adenovirus-mediated endostatin delivery results in inhibition of mammary gland tumor growth in C3(1)/SV40 T-antigen transgenic mice.
    Calvo A; Feldman AL; Libutti SK; Green JE
    Cancer Res; 2002 Jul; 62(14):3934-8. PubMed ID: 12124322
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the mammary carcinoma angiogenic switch in C3(1)/SV40 transgenic mice by a mutated form of human endostatin.
    Calvo A; Yokoyama Y; Smith LE; Ali I; Shih SC; Feldman AL; Libutti SK; Sundaram R; Green JE
    Int J Cancer; 2002 Sep; 101(3):224-34. PubMed ID: 12209972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Adenovirus-mediated gene transfer of endostatin in vivo results in high level of transgene expression and inhibition of tumor growth and metastases.
    Sauter BV; Martinet O; Zhang WJ; Mandeli J; Woo SL
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4802-7. PubMed ID: 10758166
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antitumoral effect of endostatin and angiostatin is associated with a down-regulation of vascular endothelial growth factor expression in tumor cells.
    Hajitou A; Grignet C; Devy L; Berndt S; Blacher S; Deroanne CF; Bajou K; Fong T; Chiang Y; Foidart JM; Noël A
    FASEB J; 2002 Nov; 16(13):1802-4. PubMed ID: 12354694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intratumoral administration of endostatin plasmid inhibits vascular growth and perfusion in MCa-4 murine mammary carcinomas.
    Ding I; Sun JZ; Fenton B; Liu WM; Kimsely P; Okunieff P; Min W
    Cancer Res; 2001 Jan; 61(2):526-31. PubMed ID: 11212245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of endostatin antiangiogenesis gene therapy in vitro and in vivo.
    Jin X; Bookstein R; Wills K; Avanzini J; Tsai V; LaFace D; Terracina G; Shi B; Nielsen LL
    Cancer Gene Ther; 2001 Dec; 8(12):982-9. PubMed ID: 11781661
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of therapeutic antitumor antiangiogenesis by intratumoral injection of genetically engineered endostatin-producing Semliki Forest virus.
    Yamanaka R; Zullo SA; Ramsey J; Onodera M; Tanaka R; Blaese M; Xanthopoulos KG
    Cancer Gene Ther; 2001 Oct; 8(10):796-802. PubMed ID: 11687903
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraocular expression of endostatin reduces VEGF-induced retinal vascular permeability, neovascularization, and retinal detachment.
    Takahashi K; Saishin Y; Saishin Y; Silva RL; Oshima Y; Oshima S; Melia M; Paszkiet B; Zerby D; Kadan MJ; Liau G; Kaleko M; Connelly S; Luo T; Campochiaro PA
    FASEB J; 2003 May; 17(8):896-8. PubMed ID: 12670875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum endostatin predicts tumor vascularity in hepatocellular carcinoma.
    Dhar DK; Ono T; Yamanoi A; Soda Y; Yamaguchi E; Rahman MA; Kohno H; Nagasue N
    Cancer; 2002 Nov; 95(10):2188-95. PubMed ID: 12412173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 2-difluoromethylornithine and dehydroepiandrosterone inhibit mammary tumor progression but not mammary or prostate tumor initiation in C3(1)/SV40 T/t-antigen transgenic mice.
    Green JE; Shibata MA; Shibata E; Moon RC; Anver MR; Kelloff G; Lubet R
    Cancer Res; 2001 Oct; 61(20):7449-55. PubMed ID: 11606379
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of tumor growth in xenografted nude mice with adenovirus-mediated endostatin gene comparison with recombinant endostatin protein.
    Liang ZH; Wu PH; Li L; Xue G; Zeng YX; Huang WL
    Chin Med J (Engl); 2004 Dec; 117(12):1809-14. PubMed ID: 15603709
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antiangiogenic gene therapy for cancer via systemic administration of adenoviral vectors expressing secretable endostatin.
    Chen CT; Lin J; Li Q; Phipps SS; Jakubczak JL; Stewart DA; Skripchenko Y; Forry-Schaudies S; Wood J; Schnell C; Hallenbeck PL
    Hum Gene Ther; 2000 Sep; 11(14):1983-96. PubMed ID: 11020798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endostatin-cytosine deaminase fusion protein suppresses tumor growth by targeting neovascular endothelial cells.
    Ou-Yang F; Lan KL; Chen CT; Liu JC; Weng CL; Chou CK; Xie X; Hung JY; Wei Y; Hortobagyi GN; Hung MC
    Cancer Res; 2006 Jan; 66(1):378-84. PubMed ID: 16397252
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of VEGF receptors significantly impairs mammary cancer growth in C3(1)/Tag transgenic mice through antiangiogenic and non-antiangiogenic mechanisms.
    Huh JI; Calvo A; Stafford J; Cheung M; Kumar R; Philp D; Kleinman HK; Green JE
    Oncogene; 2005 Jan; 24(5):790-800. PubMed ID: 15592523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Systemic inhibition of tumor growth and tumor metastases by intramuscular administration of the endostatin gene.
    Blezinger P; Wang J; Gondo M; Quezada A; Mehrens D; French M; Singhal A; Sullivan S; Rolland A; Ralston R; Min W
    Nat Biotechnol; 1999 Apr; 17(4):343-8. PubMed ID: 10207881
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective analysis of circulating endostatin levels in patients with renal cell carcinoma.
    Feldman AL; Alexander HR; Yang JC; Linehan WM; Eyler RA; Miller MS; Steinberg SM; Libutti SK
    Cancer; 2002 Oct; 95(8):1637-43. PubMed ID: 12365010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased levels of tissue endostatin in human malignant gliomas.
    Morimoto T; Aoyagi M; Tamaki M; Yoshino Y; Hori H; Duan L; Yano T; Shibata M; Ohno K; Hirakawa K; Yamaguchi N
    Clin Cancer Res; 2002 Sep; 8(9):2933-8. PubMed ID: 12231538
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum levels of vascular endothelial growth factor, basic fibroblast growth factor and endostatin in human metastatic liver tumors.
    Miyashita M; Tajiri T; Yanagi K; Shimizu T; Futami R; Sasajima K; Tokunaga A
    Hepatogastroenterology; 2003; 50(50):308-9. PubMed ID: 12749209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderate antiangiogenic activity by local, transgenic expression of endostatin in Rip1Tag2 transgenic mice.
    Schaffhauser B; Veikkola T; Strittmatter K; Antoniadis H; Alitalo K; Christofori G
    J Leukoc Biol; 2006 Oct; 80(4):669-76. PubMed ID: 16793908
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhancement of radiation effects by pXLG-mEndo in a lung carcinoma model.
    Luo X; Slater JM; Gridley DS
    Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):553-64. PubMed ID: 15964154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.